USD 2.67
(1.6%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -3.15 Million USD | 48.62% |
2022 | -6.14 Million USD | 2.6% |
2021 | -6.3 Million USD | -176.42% |
2020 | -2.28 Million USD | -18.67% |
2019 | -1.92 Million USD | -1.85% |
2018 | -1.88 Million USD | -98.11% |
2017 | -953 Thousand USD | 46.34% |
2016 | -1.77 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -853 Thousand USD | 22.31% |
2024 Q2 | -885 Thousand USD | -3.75% |
2023 Q1 | -814 Thousand USD | -58.06% |
2023 Q3 | -550 Thousand USD | 20.86% |
2023 Q2 | -695 Thousand USD | 14.62% |
2023 FY | -3.15 Million USD | 48.62% |
2023 Q4 | -1.09 Million USD | -99.64% |
2022 Q3 | -1.41 Million USD | -4.81% |
2022 Q2 | -1.35 Million USD | 52.73% |
2022 Q1 | -2.86 Million USD | -74.5% |
2022 Q4 | -515 Thousand USD | 63.66% |
2022 FY | -6.14 Million USD | 2.6% |
2021 Q4 | -1.63 Million USD | -43.52% |
2021 Q1 | -704 Thousand USD | -3.38% |
2021 Q2 | -826 Thousand USD | -17.33% |
2021 Q3 | -1.14 Million USD | -38.26% |
2021 FY | -6.3 Million USD | -176.42% |
2020 Q2 | -530 Thousand USD | -4.33% |
2020 Q1 | -508 Thousand USD | -62.82% |
2020 Q4 | -681 Thousand USD | -24.95% |
2020 FY | -2.28 Million USD | -18.67% |
2020 Q3 | -545 Thousand USD | -2.83% |
2019 Q2 | -1.07 Million USD | -75.33% |
2019 FY | -1.92 Million USD | -1.85% |
2019 Q4 | -312 Thousand USD | -521.62% |
2019 Q3 | 74 Thousand USD | 106.9% |
2019 Q1 | -612 Thousand USD | -8.32% |
2018 FY | -1.88 Million USD | -98.11% |
2018 Q3 | -754 Thousand USD | -162.72% |
2018 Q4 | -565 Thousand USD | 25.07% |
2018 Q1 | -369 Thousand USD | -90.21% |
2018 Q2 | -287 Thousand USD | 22.22% |
2017 FY | -953 Thousand USD | 46.34% |
2017 Q4 | -194 Thousand USD | 0.0% |
2016 FY | -1.77 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Akoya Biosciences, Inc. | -63.32 Million USD | 95.014% |
AngioDynamics, Inc. | -184.34 Million USD | 98.287% |
AtriCure, Inc. | -30.43 Million USD | 89.628% |
Avinger, Inc. | -18.32 Million USD | 82.767% |
Azenta, Inc. | -14.25 Million USD | 77.856% |
BioLife Solutions, Inc. | -66.42 Million USD | 95.247% |
The Cooper Companies, Inc. | 294.2 Million USD | 101.073% |
Daxor Corporation | 280.64 Thousand USD | 1224.929% |
Ekso Bionics Holdings, Inc. | -15.19 Million USD | 79.228% |
Femasys Inc. | -14.24 Million USD | 77.841% |
GlucoTrack, Inc. | -7.09 Million USD | 55.516% |
Harvard Bioscience, Inc. | -3.41 Million USD | 7.555% |
Hologic, Inc. | 789.5 Million USD | 100.4% |
ICU Medical, Inc. | -29.65 Million USD | 89.354% |
Intuitive Surgical, Inc. | 1.79 Billion USD | 100.176% |
KORU Medical Systems, Inc. | -13.74 Million USD | 77.025% |
LeMaitre Vascular, Inc. | 30.1 Million USD | 110.487% |
Innovative Eyewear, Inc. | -6.66 Million USD | 52.622% |
Innovative Eyewear, Inc. | -6.66 Million USD | 52.622% |
Masimo Corporation | 81.5 Million USD | 103.874% |
Microbot Medical Inc. | -10.74 Million USD | 70.605% |
Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 127.156% |
Merit Medical Systems, Inc. | 94.41 Million USD | 103.344% |
Nephros, Inc. | -1.57 Million USD | -100.444% |
NovoCure Limited | -207.04 Million USD | 98.475% |
NEXGEL, Inc. | -3.15 Million USD | -0.0% |
Singular Genomics Systems, Inc. | -94.82 Million USD | 96.671% |
OraSure Technologies, Inc. | 53.65 Million USD | 105.884% |
Pro-Dex, Inc. | 2.12 Million USD | 248.425% |
Pulse Biosciences, Inc. | -42.21 Million USD | 92.521% |
Predictive Oncology Inc. | -13.98 Million USD | 77.424% |
Precision Optics Corporation, Inc. | -2.95 Million USD | -6.967% |
QuidelOrtho Corporation | -10.1 Million USD | 68.743% |
Repligen Corporation | 41.57 Million USD | 107.593% |
Sanara MedTech Inc. | -4.3 Million USD | 26.636% |
STAAR Surgical Company | 21.34 Million USD | 114.789% |
Sharps Technology, Inc. | -9.84 Million USD | 67.922% |
Utah Medical Products, Inc. | 16.63 Million USD | 118.978% |
DENTSPLY SIRONA Inc. | -132 Million USD | 97.608% |
Jin Medical International Ltd. | 2.87 Million USD | 209.685% |